(firstQuint)Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon.

 The registry is a prospective, multi-center, single-arm, real-world study to assess the clinical use of the Bard(R) UltraScore cent Focused Force PTA balloon for the treatment of stenotic lesions of the superficial femoral artery (SFA), popliteal artery, and infra-popliteal arteries (posterior tibial, anterior tibial and peroneal arteries).

 Follow-up for all treated subjects will be performed at hospital discharge, 30 days, and 6 and 12 months post-index procedure.

.

 Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon@highlight

The objective of this study is to assess the clinical use of the Bard(R) UltraScore cent Focused Force PTA balloon in a heterogeneous patient population in a real world, on-label clinical application.

